Shopping Cart

Expired activity

Please go to the PowerPak homepage and select a course.

OVERVIEW

About one-third of all patients with diabetes use injectable insulin therapy, and this number will likely grow with the introduction of glucagon-like peptide-1 (GLP-1) receptor agonists. Unfortunately, about one-third of patients with diabetes who use injectables acknowledge a level of dread associated with self injection, which can lead to missed doses, resulting in poor outcomes. Community pharmacists are generally the last healthcare provider a patient will encounter when receiving a prescription, putting the pharmacist in a unique position to be able to address patient concerns and barriers to self-injection as well as provide critical patient education. This enduring activity will address patient engagement and education regarding injectable diabetes therapy via a video case study, an educational demonstration of self-injection techniques, and practical strategies and tools for improving and individualizing such techniques and overall diabetes management.

GOAL

The goal of this interactive activity is to provide community pharmacists with the tools to confidently counsel patients with diabetes on the use of their injectable medications (ie, insulin therapies, GLP-1 therapies, and pramlintide).

TARGET AUDIENCE

This activity is designed for community pharmacists. No prerequisites required.

LEARNING OBJECTIVES

The University of Tennessee College of Pharmacy takes responsibility for the content, quality, and scientific integrity of this CPE activity. At the conclusion of this activity, the participant should be able to:

• DISCUSS recently approved injectable therapies for diabetes.
• DEMONSTRATE to patients the correct use of an insulin syringe and vial and the currently available insulin pens.
• IDENTIFY strategies to assess patient baseline knowledge of diabetes injectable medications.
• PROVIDE effective diabetes patient education targeting self-management behaviors and injection technique.
• DISCUSS implementation strategies for motivational interviewing methods to help patients cope with social challenges and increase patient adherence with diabetes therapies.

CONTINUING EDUCATION INFORMATION

The University of Tennessee College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Successful completion of this application-based activity will provide a statement for 1.0 contact hour of credit (0.1 CEU) and will be available at the completion of the activity. Successfully completing the activity and receiving credit includes: 1) reading the learning objectives and faculty disclosures; 2) studying the educational activity; 3) evaluating the activity; and, 4) completing the self-assessment instrument with a score of at least 70%.  UAN:  0064-0000-17-209-H01-P. CE credit will be submitted to the NABP CPE Monitor within 30 days. It is recommended that you check your NABP CPE Monitor e-profile database 30 days after the completion of any CE activity to ensure that your credits are posted.

NABP e-PROFILE ID NUMBER: Pharmacists or pharmacy technicians with questions regarding their NABP e-Profile or CPE Monitor should refer to the FAQ section on the NABP website: https://nabp.pharmacy/cpe-monitor-service/cpe-monitor-faqs/. To receive credit for your participation in this activity, all pharmacists must include their NABP e-Profile ID number, along with their month and date of birth. If incorrect information is provided, this will result in "rejected" status from the CPE Monitor. It is the responsibility of the participant to notify The University of Tennessee (within the 60 day submission timeframe) of their corrected information. Otherwise, the completed CE will not be accepted by the CPE Monitor.

Please allow up to 30 days for your credit to appear on CPE Monitor.

The estimated time to complete this activity: 1.0 hour.

Release date: April 10, 2017
Expiration date: April 10, 2018

FULL DISCLOSURE POLICY AFFECTING CPE ACTIVITIES

As an accredited provider by the Accreditation Council for Pharmacy Education (ACPE), it is the policy of The University of Tennessee College of Pharmacy to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The Course Director and Participating Faculty reported the following:

PARTICIPATING FACULTY

Nancy B. Hart, PharmD, BCPS
Associate Professor
University of Tennessee Health Science Center
College of Pharmacy Department of Clinical Pharmacy
Nashville, Tennessee
Dr Hart reports holding stock in Publix (as a Floater Pharmacist).

James Wheeler, PharmD, BCPS
Assistant Professor Clinical Pharmacy
Director of Continuing Professional Development
College of Pharmacy
University of Tennessee Health Science Center
Nashville, Tennessee
Dr Wheeler reports having no relevant financial or advisory relationships with corporate organizations related to this activity.

Reviewer
Denise E. Barker, DPh
Area 4 Patient Care Coordinator
Nashville Division
The Kroger Co.
Farragut, Tennessee

OFF-LABEL PRODUCT DISCUSSION

In accordance with ACPE Criteria for Quality, the audience is advised that authors in this CPE activity may include reference(s) to unlabeled, unapproved, or investigational uses of therapeutic agents or biomedical devices. The authors will inform the reader of when they discuss or reference an unapproved, unlabeled, or investigational use of therapeutic agent or biomedical device.

DISCLAIMER STATEMENT

The opinions and recommendations expressed by faculty and other experts whose input is included in this activity are their own. This activity is produced for educational purposes only. Use of The University of Tennessee College of Pharmacy name implies review of educational format, design, and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients.

GRIEVANCE POLICY

A participant, provider, faculty member, or other individual wanting to file a grievance with respect to any aspect of an activity provided or coprovided by The University of Tennessee College of Pharmacy may contact the Associate Dean for Continuing Education in writing at gfarr@utasip.com. The grievance will be reviewed and a response will be returned within 45 days of receiving the written statement. If not satisfied, an appeal to the Dean of the College of Pharmacy can be made for a second level review.

FEE INFORMATION

There is no fee for this educational activity.

ACTIVITY

Please complete the preassessment, listen to and watch the following presentation, and complete the postassessment and evaluation to receive CPE credit for this activity. A statement of credit will be available online immediately following successful completion of the activity.

Preassessment

• Case Presentation
• Review of Injectable Therapies for Diabetes
• Teach-back Method for Self-injection
• Addressing Concerns
• Motivational Interviewing
• Conclusions

Postassessment

What you are about to see is a previously recorded live meeting. Please note that only "home study" credit will be awarded for participating in this archived presentation.
No "live" credits are available.